New findings on optimal duration of trastuzumab therapy for women
Long awaited results constitute a further milestone
Cancer in the Movies
It’s time cinema directors realised cancer isn’t always a death sentence, a new study shows
Studies show advances in gastrointestinal cancer treatments
Phase III data reported at ESMO 2012
Urgent need for integrated oncology and palliative care
ESMO 2012 emphasises palliative care: 16 new ESMO Designated Centres of Integrated Oncology and Palliative Care honoured New research providing snap-shot of palliative care in Italy
Phase III MISSION trial
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer, EGFR status may help select patients who will benefit most
Should aspirin be used to prevent cancer?
Debate at ESMO 2012 Congress focuses on whether there is enough evidence to start using aspirin to reduce the risk of colorectal cancer
ESMO 2012 Press Release: New weapons in the fight against cancer
Where are the most promising developments from first-in-human studies?
The true costs of cancer in Europe revealed
The first ever estimate of the economic burden of cancer in Europe shows that it exceeds 124 billion euros